Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-30, Stock:JNJ, The news for the past five days is as follows:
2018-07-23: NEWS1: Johnson & Johnson Is a Great Company, But Be Patient.NEWS2: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS3: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS4: MARKETS: Why Trump is talking down bonds and the dollar, but stocks are just shrugging.NEWS5: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS6: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS7: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS8: Oncology Portfolio Sales Drove J&J’s Pharmaceuticals Business.NEWS9: Why J&J’s Consumer Business Didn’t Meet Expectations in Q2 2018.
2018-07-24: NEWS1: What to Expect from Edwards Lifesciences’ Q2 2018 Results.NEWS2: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS3: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS4: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS5: Why Most Analysts Are Bullish on Baxter International.NEWS6: Novartis’s Q2 2018 Earnings: Alcon.NEWS7: What Drove Growth for J&J’s Medical Device Business?.NEWS8: Pharma/Biotech Stock Q2 Earnings on Jul 25: GILD, VRTX & GSK.NEWS9: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical.NEWS10: Analysts’ Targets and Recommendations for Amgen Stock.NEWS11: J&J’s Oncology Franchise Saw 42.2% Growth in Q2 2018.NEWS12: GSK JV ViiV Healthcare Presents Data From Two Phase III Studies.NEWS13: GSK JV ViiV Healthcare Presents Data From Two Phase III Studies.
2018-07-25: NEWS1: 3 Great Stocks for Retirees to Own.NEWS2: Understanding the Components and the Concept of Alpha.NEWS3: Understanding the Components and the Concept of Alpha.NEWS4: Why Most Analysts Are Bullish on NovoCure.NEWS5: Thermo Fisher’s Q2 2018 Earnings Surpass Analysts’ Estimates.NEWS6: Understanding the Components and the Concept of Alpha.NEWS7: SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow.NEWS8: SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow.NEWS9: Pfizer to Build Sterile Injectable Facility in Michigan.NEWS10: The Top 4 UPS Shareholders (UPS).NEWS11: Estimates and Recommendations for Thermo Fisher on July 24.NEWS12: Did This Top Biotech Stock Just Go on Sale?.NEWS13: Did This Top Biotech Stock Just Go on Sale?.NEWS14: Thermo Fisher’s Q2 2018 Estimates: Revenue Growth Expected.NEWS15: Novartis’s Valuation after Its Q2 2018 Earnings.NEWS16: Did This Top Biotech Stock Just Go on Sale?.
2018-07-26: NEWS1: Fight Inflation With Prudent Stock Market Investing.NEWS2: Fight Inflation With Prudent Stock Market Investing.NEWS3: Celgene Raises Revenue Guidance after Solid Growth in Q2 2018.NEWS4: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS5: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS6: Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook.NEWS7: Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook.NEWS8: Fight Inflation With Prudent Stock Market Investing.NEWS9: Dow Movers: V, TRV.NEWS10: Dow Movers: V, TRV.NEWS11: 3 Stocks That Could Double Your Money.NEWS12: 3 Stocks That Could Double Your Money.NEWS13: 5 Dow Jones Stocks That Are Ready to Rise Again.NEWS14: 3 Stocks That Could Double Your Money.
2018-07-27: NEWS1: All New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 7/27/18).NEWS2: NYSE trader: Consumers are slowly retrenching because of trade uncertainty.NEWS3: Noteworthy Friday Option Activity: JNJ, STZ, REGN.NEWS4: Noteworthy Friday Option Activity: JNJ, STZ, REGN.NEWS5: AbbVie's (ABBV) Q2 Earnings Beat Estimates, 2018 View Up.NEWS6: AbbVie's (ABBV) Q2 Earnings Beat Estimates, 2018 View Up.NEWS7: Collaborations Help Alkermes Flip to Profitability.NEWS8: Collaborations Help Alkermes Flip to Profitability.NEWS9: Pfizer’s Q2 2018 Estimates: Expect Revenue Growth.NEWS10: Collaborations Help Alkermes Flip to Profitability.NEWS11: Pharma Favorites: 7 Healthy Picks in the Drug Sector.

Answer: Rise